SCHEMBL900224

SCHEMBL900224

OC/C1=C(\CO)CCCCCC1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
ALDH1A1 P00352 1/20 0.32
TRIM24 O15164 1/20 0.32
TRIM33 Q9UPN9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL789662 0.96
SCHEMBL1831137 0.89
SCHEMBL6538240 0.84
SCHEMBL9007698 0.81
SCHEMBL11012366 0.80 TSHR (0.32) TSHRCASP1
SCHEMBL3938413 0.78
SCHEMBL15424371 0.78
SCHEMBL6538233 0.76
SCHEMBL6539087 0.76
SCHEMBL19753632 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621990-B1 THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM BLUE CUBE IP LLC (US) 2016-02-24 EP claimed
EP-2621991-B1 PROCESS FOR PREPARING EPOXY RESINS DOW GLOBAL TECHNOLOGIES LLC (US) 2015-07-01 EP claimed
US-8962792-B2 Process for preparing epoxy resins DOW GLOBAL TECHNOLOGIES LLC (US) 2015-02-24 US claimed
US-20140194554-A1 EPOXY RESIN COMPOSITIONS DOW GLOBAL TECHNOLOGIES LLC (US) 2014-07-10 US claimed
US-20130302336-A1 DISULFIDE STABILIZED DVD-IG MOLECULES UCB PHARMA S.A. (BE) 2013-11-14 US claimed
US-20130237642-A1 THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2013-09-12 US claimed
EP-2621994-A1 EPOXY RESIN COMPOSITIONS Dow Global Technologies LLC (US) 2013-08-07 EP claimed
EP-2621991-A1 PROCESS FOR PREPARING EPOXY RESINS Dow Global Technologies LLC (US) 2013-08-07 EP claimed
EP-2621990-A2 THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM Dow Global Technologies LLC (US) 2013-08-07 EP claimed
US-20130178601-A1 PROCESS FOR PREPARING EPOXY RESINS DOW GLOBAL TECHNOLOGIES LLC (US) 2013-07-11 US claimed
WO-2012047420-A2 THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2012-04-12 WO claimed
WO-2012044442-A1 PROCESS FOR PREPARING EPOXY RESINS DOW GLOBAL TECHNOLOGIES LLC (US) 2012-04-05 WO claimed
WO-2012044443-A1 EPOXY RESIN COMPOSITIONS DOW GLOBAL TECHNOLOGIES LLC (US) 2012-04-05 WO claimed
EP-2621995-B1 ADVANCED EPOXY RESIN COMPOSITIONS DOW GLOBAL TECHNOLOGIES LLC (US) 2016-03-23 EP disclosed
US-9284434-B2 Epoxy resin compositions BLUE CUBE IP LLC (US) 2016-03-15 US disclosed
EP-2621990-B1 THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM BLUE CUBE IP LLC (US) 2016-02-24 EP disclosed
WO-2012050777-A1 ADVANCED POLY EPOXY ESTER RESIN COMPOSITIONS DOW GLOBAL TECHNOLOGIES LLC (US) 2012-04-19 WO disclosed
WO-2012047420-A2 THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2012-04-12 WO disclosed
WO-2012044458-A1 ADVANCED EPOXY RESIN COMPOSITIONS DOW GLOBAL TECHNOLOGIES LLC (US) 2012-04-05 WO disclosed
WO-2012044443-A1 EPOXY RESIN COMPOSITIONS DOW GLOBAL TECHNOLOGIES LLC (US) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130302336-A1 DISULFIDE STABILIZED DVD-IG MOLECULES EED, DRD2, PSMD14 TSHR 3032/4885CASP1 4099/4885ALDH1A1 1076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.